Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
5.26
-0.13 (-2.41%)
Oct 6, 2025, 4:00 PM EDT - Market closed
Adverum Biotechnologies Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$19.75
Upside
+275.48%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +470.34% | Sep 23, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +527.38% | Aug 13, 2025 |
| Mizuho | Mizuho | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | +128.14% | Jun 26, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | -23.95% | May 15, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +527.38% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +470.34% | May 15, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $40 → $33 | Strong Buy | Maintains | $40 → $33 | +527.38% | Apr 17, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $10 → $5 | Hold | Maintains | $10 → $5 | -4.94% | Apr 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +470.34% | Apr 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +470.34% | Nov 19, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $12 → $10 | Hold | Maintains | $12 → $10 | +90.11% | Nov 5, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $60 → $40 | Strong Buy | Maintains | $60 → $40 | +660.46% | Aug 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +470.34% | Aug 13, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $15 → $12 | Hold | Maintains | $15 → $12 | +128.14% | Aug 13, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $4 → $40 | Strong Buy | Maintains | $4 → $40 | +660.46% | Jul 18, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $25 | Buy | Initiates | $25 | +375.29% | Jun 25, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.